2025-12-11T18:20:10Z
2025-12-11T18:20:10Z
2024-05-25
2025-12-11T18:20:10Z
C-Jun-N-terminal-kinases (JNKs), members of the mitogen-activated-protein-kinase family, are significantly linked with neurological and neurodegenerative pathologies and cancer progression. However, JNKs serve key roles under physiological conditions, particularly within the central-nervous-system (CNS), where they are critical in governing neural proliferation and differentiation during both embryogenesis and adult stages. These processes control the development of CNS, avoiding neurodevelopment disorders. JNK are key to maintain the proper activity of neural-stem-cells (NSC) and neural-progenitors (NPC) that exist in adults, which keep the convenient brain plasticity and homeostasis. This review underscores how the interaction of JNK with upstream and downstream molecules acts as a regulatory mechanism to manage the self-renewal capacity and differentiation of NSC/NPC during CNS development and in adult neurogenic niches. Evidence suggests that JNK is reliant on non-canonical Wnt components, Fbw7-ubiquitin-ligase, and WDR62-scaffold-protein, regulating substrates such as transcription factors and cytoskeletal proteins. Therefore, understanding which pathways and molecules interact with JNK will bring knowledge on how JNK activation orchestrates neuronal processes that occur in CNS development and brain disorders.
Article
Versió publicada
Anglès
Malalties neurodegeneratives; Neurogenètica; Neurodegenerative Diseases; Neurogenetics
Elsevier
Reproducció del document publicat a: https://doi.org/10.1016/j.lfs.2024.122750
Life Sciences, 2024, vol. 350
https://doi.org/10.1016/j.lfs.2024.122750
cc-by (c) Castro-Torres, Rubén Darío et al., 2024
http://creativecommons.org/licenses/by/4.0/